A carregar...
High Dose Intravitreal Bevacizumab for Refractory Pigment Epithelial Detachment in Age-related Macular Degeneration
PURPOSE: Intravitreal anti-vascular endothelial growth factor (anti-VEGF) is the first choice of treatment for age-related macular degeneration. However, quite a few eyes treated using conventional dose anti-VEGF (CDAV) have persistent pigment epithelial detachment (PED) on optical coherence tomogra...
Na minha lista:
| Publicado no: | Korean J Ophthalmol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
The Korean Ophthalmological Society
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4965601/ https://ncbi.nlm.nih.gov/pubmed/27478353 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3341/kjo.2016.30.4.265 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|